Amphastar Pharmaceuticals, Inc.AMPHNASDAQ
Loading
Enterprise value to sales ratio
3Y CAGR
-2.7%/yr
vs -3.4%/yr prior
5Y CAGR
-1.7%/yr
Consistent
Acceleration
+0.7pp
Accelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive declineFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.41 | -23.1% |
| 2024 | 3.14 | -41.6% |
| 2023 | 5.38 | +105.3% |
| 2022 | 2.62 | +5.1% |
| 2021 | 2.49 | -5.3% |
| 2020 | 2.63 | -5.5% |
| 2019 | 2.78 | -7.5% |
| 2018 | 3.01 | -16.8% |
| 2017 | 3.62 | +15.2% |
| 2016 | 3.14 | - |